![]() Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. | ![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2016 | Founding Date 2003 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 286 | Employees 172 |
Financial | ||
Net income | Net income ($255.3m) (FY, 2019) | Net income ($154.9m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 149.3m |
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company